
Sponsored
Advertisement


Advertisement


Sponsored Content


Advertisement












How Novel Technologies and Opioid Alternatives Can Improve Patient Outcomes

Sponsored by Takeda Pharmaceuticals


A secukinumab researcher explains why the practice may become the "next stethoscope" of medicine.




This ad was supported by Church & Dwight Co. Inc, featuring Feryal Hajee, MD.



An examination of the physical, emotional and social burden of psoriasis, and the continued need for research to advance care for patients.

Frank Trudo, MD, MBA, was recently appointed as VP, US Respiratory, Medical Affairs, at AstraZeneca.
Advertisement
Advertisement
Trending on HCPLive
1
Single Dose of CIDEB siRNA Normalizes Liver Fat in MASLD Through 36 Weeks
2
Lp(a)HORIZON, Oral PCSK9s, and 2027 Lipid Trials, with Kausik Ray, MD, MBChB, MPhil
3
COMP360 Psilocybin NDA Submitted to FDA for Treatment-Resistant Depression
4
Elebsiran Plus Tobevibart Suppresses HDV RNA in Phase 3 ECLIPSE 1 Trial
5